Page last updated: 2024-08-25

tocophersolan and Acute Lymphoid Leukemia

tocophersolan has been researched along with Acute Lymphoid Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Jimenez-Del-Rio, M; Mendivil-Perez, M; Velez-Pardo, C1
Jimenez-Del-Rio, M; Lopez-Osorio, B; Ruiz-Moreno, C; Sierra-Garcia, L; Velez-Pardo, C1

Other Studies

2 other study(ies) available for tocophersolan and Acute Lymphoid Leukemia

ArticleYear
TPEN/TPGS (T2) combo dramatically reduces Philadelphia chromosome-positive pro-lymphoblastic B leukemia in BALB/c mice.
    Medical oncology (Northwood, London, England), 2022, Nov-09, Volume: 40, Issue:1

    Topics: Adult; Animals; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2022
Vitamin E synthetic derivate-TPGS-selectively induces apoptosis in jurkat t cells via oxidative stress signaling pathways: implications for acute lymphoblastic leukemia.
    Apoptosis : an international journal on programmed cell death, 2016, Volume: 21, Issue:9

    Topics: Apoptosis; DNA Fragmentation; Humans; Jurkat Cells; Oxidative Stress; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Signal Transduction; Vitamin E

2016